MPI will attend 9th Swiss-Scandinavian Bio-Business Seminar 

February 5, 2015 - Zürich, Switzerland

Please contact Claus Deichgræber

Venlighedsvej 1  DK-2970 Hoersholm Denmark  CVR: 28106351

Innovating Prediction

          -Improving Cancer Survival

MPI is an international Biotech/IT company specializing in Precision Medicine by the creation of Biomarkers and development of Companion Diagnostics for the treatment of cancer.

Hør CEO Peter Buhl Jensen fortælle om MPI